Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer.


Journal

The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539

Informations de publication

Date de publication:
2022
Historique:
received: 28 04 2022
revised: 29 10 2022
accepted: 01 11 2022
entrez: 7 12 2022
pubmed: 8 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Identifying and understanding modifiable factors for the well-being of cancer patients is critical in survivorship research. We studied variables associated with the exercise habits of breast cancer patients and investigated if the achievement of exercise recommendations was associated with enhanced quality of life and/or psychological well-being. At the beginning of adjuvant therapy and after twelve months, 32% and 26% of participants were physically inactive, 27% and 30% exercised between 30 and 150 minutes per week, while 41% and 45% exercised the recommended 150 minutes or more per week. Relative to other countries, Finnish participants were more likely to be active at baseline and at twelve months (89% vs. 50%, For women with early breast cancer, exercise was associated with a better quality of life, less depression and anxiety, and fewer adverse events of adjuvant therapy. Trial registration number: NCT05095675. Paula Poikonen-Saksela on behalf of Bounce consortium (https://www.bounce-project.eu/).

Sections du résumé

Background
Identifying and understanding modifiable factors for the well-being of cancer patients is critical in survivorship research. We studied variables associated with the exercise habits of breast cancer patients and investigated if the achievement of exercise recommendations was associated with enhanced quality of life and/or psychological well-being.
Results
At the beginning of adjuvant therapy and after twelve months, 32% and 26% of participants were physically inactive, 27% and 30% exercised between 30 and 150 minutes per week, while 41% and 45% exercised the recommended 150 minutes or more per week. Relative to other countries, Finnish participants were more likely to be active at baseline and at twelve months (89% vs. 50%,
Conclusion
For women with early breast cancer, exercise was associated with a better quality of life, less depression and anxiety, and fewer adverse events of adjuvant therapy. Trial registration number: NCT05095675. Paula Poikonen-Saksela on behalf of Bounce consortium (https://www.bounce-project.eu/).

Identifiants

pubmed: 36474966
doi: 10.1155/2022/9921575
pmc: PMC9701120
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9921575

Informations de copyright

Copyright © 2022 Leena Vehmanen et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Cochrane Database Syst Rev. 2018 Jan 29;1:CD011292
pubmed: 29376559
Cancers (Basel). 2019 May 22;11(5):
pubmed: 31121916
PLoS One. 2012;7(1):e30955
pubmed: 22303474
Breast. 2019 Apr;44:144-152
pubmed: 30780085
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Br J Sports Med. 2018 Oct;52(20):1311
pubmed: 29549149
J Clin Oncol. 1996 Oct;14(10):2756-68
pubmed: 8874337
BMJ Open Sport Exerc Med. 2021 Feb 01;7(1):e000960
pubmed: 34192010
Anticancer Res. 2012 Sep;32(9):3875-84
pubmed: 22993332
Cancers (Basel). 2021 Jan 12;13(2):
pubmed: 33445739
Bull Cancer. 2020 Oct;107(10):1042-1055
pubmed: 32977937
Ann Behav Med. 2011 Feb;41(1):32-47
pubmed: 20931309
JAMA Oncol. 2022 Mar 01;8(3):395-403
pubmed: 34989765
Ann Oncol. 2014 Jul;25(7):1293-1311
pubmed: 24644304
Cochrane Database Syst Rev. 2016 Sep 21;9:CD005001
pubmed: 27650122
Psychooncology. 2011 Feb;20(2):115-26
pubmed: 20336645
Eur J Cancer. 2016 Jan;52:138-54
pubmed: 26687833
Int J Cancer. 2015 Jul 15;137(2):471-80
pubmed: 25484317
Support Care Cancer. 2019 Jan;27(1):9-21
pubmed: 30032399
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13037
pubmed: 30895677
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Ann Behav Med. 2002 Fall;24(4):257-68
pubmed: 12434937
Trials. 2016 Jul 28;17:363
pubmed: 27464488
Cancer. 2003 Apr 1;97(7):1746-57
pubmed: 12655532
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Breast Cancer Res. 2018 Oct 19;20(1):124
pubmed: 30340503
Breast. 2017 Apr;32:144-155
pubmed: 28189100
Front Psychol. 2020 Apr 29;11:546
pubmed: 32411035
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
In Vivo. 2019 May-Jun;33(3):881-888
pubmed: 31028212
Acta Oncol. 2015 May;54(5):635-54
pubmed: 25752971

Auteurs

Leena Vehmanen (L)

Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland.

Johanna Mattson (J)

Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland.

Evangelos Karademas (E)

Department of Psychology, University of Crete, Rethymno, Greece.
Foundation for Research and Technology-Hellas, Institute of Computer Science, Heraklion, Greece.

Albino J Oliveira-Maia (AJ)

Champalimaud Research & Clinical Centre, Champalimaud Foundation, Lisboa, Portugal.
NOVA Medical School NMS, Universidade Nova de Lisboa, Lisboa, Portugal.

Berta Sousa (B)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisboa, Portugal.

Ruth Pat-Horenczyk (R)

School of Social Work and Social Welfare, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ketti Mazzocco (K)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

Panagiotis Simos (P)

Foundation for Research and Technology-Hellas, Institute of Computer Science, Heraklion, Greece.
School of Medicine, University of Crete, Rethymno, Greece.

Fátima Cardoso (F)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisboa, Portugal.

Greta Pettini (G)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Chiara Marzorati (C)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Eleni Kolokotroni (E)

In Silico Oncology and In Silico Medicine Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.

Georgios Stamatakos (G)

In Silico Oncology and In Silico Medicine Group, Institute of Communication and Computer Systems, School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.

Diana Frasquilho (D)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisboa, Portugal.

Paula Poikonen-Saksela (P)

Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH